Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Hammerness

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Pediatrics|April 28, 2009
Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorderPaul Hammerness, Timothy Wilens, Eric Mick, et al.
Journal of the Society for Integrative Oncology|May 30, 2009
Maitake mushroom (Grifola frondosa): systematic review by the natural standard research collaborationCatherine Ulbricht, Wendy Weissner, Ethan Basch, et al.
Journal of Child and Adolescent Psychopharmacology|November 3, 2009
An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. EffectivenessTimothy E Wilens, Paul Hammerness, Linsey Utzinger, et al.
CNS Neuroscience & Therapeutics|April 27, 2010
A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorderJoseph Biederman, Gagan Joshi, Eric Mick, et al.
CNS Spectrums|September 7, 2007
An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorderJoseph Biederman, Eric Mick, Thomas Spencer, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 8, 2012
A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorderPaul Hammerness, Randall Zusman, David Systrom, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot studyJoseph Biederman, Eric Mick, Stephen Faraone, et al.
Journal of Herbal Pharmacotherapy|July 28, 2004
Chaparral monograph:a clinical decision support toolCatherine Ulbricht, Ethan Basch, Mamta Vora, et al.
BMC Psychiatry|September 18, 2007
Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorderJoseph Biederman, Eric O Mick, Craig Surman, et al.
CNS Spectrums|April 28, 2006
An open-label trial of OROS methylphenidate in adults with late-onset ADHDJoseph Biederman, Eric Mick, Thomas Spencer, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Pediatrics|April 28, 2009
Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorderPaul Hammerness, Timothy Wilens, Eric Mick, et al.
Journal of the Society for Integrative Oncology|May 30, 2009
Maitake mushroom (Grifola frondosa): systematic review by the natural standard research collaborationCatherine Ulbricht, Wendy Weissner, Ethan Basch, et al.
Journal of Child and Adolescent Psychopharmacology|November 3, 2009
An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. EffectivenessTimothy E Wilens, Paul Hammerness, Linsey Utzinger, et al.
CNS Neuroscience & Therapeutics|April 27, 2010
A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorderJoseph Biederman, Gagan Joshi, Eric Mick, et al.
CNS Spectrums|September 7, 2007
An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorderJoseph Biederman, Eric Mick, Thomas Spencer, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 8, 2012
A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorderPaul Hammerness, Randall Zusman, David Systrom, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot studyJoseph Biederman, Eric Mick, Stephen Faraone, et al.
Journal of Herbal Pharmacotherapy|July 28, 2004
Chaparral monograph:a clinical decision support toolCatherine Ulbricht, Ethan Basch, Mamta Vora, et al.
BMC Psychiatry|September 18, 2007
Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorderJoseph Biederman, Eric O Mick, Craig Surman, et al.
CNS Spectrums|April 28, 2006
An open-label trial of OROS methylphenidate in adults with late-onset ADHDJoseph Biederman, Eric Mick, Thomas Spencer, et al.
Pageof 7